In patients with psoriasis, the risk of lymphoma has been a subject of controversy and data from larger studies are limited1-4 . We therefore investigated the 5-year risk of new-onset Hodgkin lymphoma (HL), non-Hodgkin lymphoma (NHL) (excluding cutaneous T-cell lymphoma [CTCL]), and CTCL, respectively, in patients with psoriasis. This article is protected by copyright. All rights reserved.
|Journal||British Journal of Dermatology|
|Publication status||Published - 18 Mar 2018|